GenPath
487 Edward H Ross Dr
Elmwood Park, NJ 07407
1 800 627 1479


© 2009 GenPath is a business unit of BioReference Laboratories, Inc.

Acute Myelogenous Leukemia Prognosis using NPM1 FLT3 and Mutation Analysis



Test Name AML Prognostic: FLT3 & NPM1 Mutation Analysis
Also Known As FLT3, NPM1, Nucleaphosmin
Panel? Yes
Clinical Utility and/or Limitations Helps understand the prognosis in AML patients. Patients with FLT3 mutations have a poor prognisis whereas those with NPM1 mutations have a good prognosis in the absence of FLT3 mutations.
Diagnosis Under Consideration AML
Method PCR and Pyrosequencing
 
Ordering Details
Test Code 5988-1
Turnaround Time 24-48hrs
Preferred Specimen and Volume 5mL Whole blood or Bone Marrow in lavender top tube
 
Specimen Handling Information
Specimen Storage Refrigerate fresh specimen until shipping, ship within 24 hrs.
Specimen Transport Room Temperature
Causes For Specimen Rejection No patient ID on Specimen, Patient ID on specimen and Requisition doesn't match, incorrect fixative (tube/solution), Specimen without GenPath/BioReference requisition. Frozen specimen.
 
Billing Information
CPT Codes 83891(1), 83894(1), 83898(1), 83900(1), 83901(3), 83904(2), 83912(2)